Article
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
2024-08-09
Abstract excerpt
SARS-CoV-2 continues to pose a threat to public health. Current therapeutics remain limited to direct acting antivirals that lack distinct mechanisms of action and are already showing signs of viral resistance. The virus encodes an ADP-ribosylhydrolase macrodomain (Mac1) that plays an important role in the coronaviral lifecycle by suppressing host innate immune responses. Genetic inactivation of Mac1 abrogates vir...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4eb0571a-fd6f-5633-a975-2cd20acc2430
- DOI
- 10.1101/2024.08.08.606661
